The causes of hepatocellular damage occurring in patients with HBsAg-positive inflammatory liver disease have not yet been clarified. Hepatitis B virus itself does not appear to induce liver lesions as large amounts of HBsAg are detected in the hepatocytes in healthy chronic carriers (Hadziyannis et al., 1972) . Recent results suggest that cell-mediated immunity may play an important role in the pathogenesis of the disease by either of two processes. The first is mediated by an immunological reaction directed against viral antigens or viral induced neoantigens and the second is an autoimmune reaction against liver specific membrane proteins. Dudley et al. (1972) suggested that in hepatitis B infection the liver cell necrosis could be related to specifically sensitised lymphocytes reacting with viral antigens on the surface of infected hepatocytes. This hypothesis is supported by the demonstration of cellmediated immune reactions to HBsAg in patients with acute hepatitis B (Gerber et al., 1974; Lee et al., 1977) ; in addition, we have recently identified, by immunofluorescence, the presence of HBsAg at the hepatocyte surface in the early phase of the disease . On the other hand, studies on cellular sensitisation to the antigen in HBsAg chronic carriers, either with or without liver disease, gave controversial results (Gerber et al., 1974; De Moura et al., 1975; Lee et al., 1975) and HBsAg could not be localised at the liver cell surface . Recent reports pointed out the possibility that the pathogenesis of chronic active hepatitis, both HBsAg-positive and negative, may be related to an antibody-dependent, K-cell mediated cellular cytotoxicity directed against liver specific membrane antigens (Cochrane et al., 1976) .
So far, cell-mediated immunity to HBsAg has been studied using the leucocyte migration inhibition and the lymphocyte transformation tests and its role in the clearance of the virus from the liver has been emphasised. The 77 and 91 %, the mean being 84-13 ± 4.44.
The mean spontaneous cytotoxic indexes against uncoated ChRBC detected in patients with acute hepatitis B (6-11 + 4 01), chronic active hepatitis (5 88 ± 5 11), and in healthy carriers of HBsAg (6 28 ± 5 22) showed no significant differences when compared with the value obtained in control subjects (5-42 + 3-33).
The cytotoxic indexes obtained with peripheral lymphocytes from controls and patients tested against HBsAg-coated target cells are shown in Fig. 1 (Table 2) . The cytotoxic activity of lymphocytes against target P 0,0I cells coated with specific antigens has been defined as an in vitro parameter of cell-mediated immunity Fig. 2 The effect ofseparated T-and B-cellpopulations (Perlmann and Holm, 1969; Henney, 1970 , 1973) , and leucocyte migration inhibition tests (Gerber et al., 1974; De Moura et al., 1975; Lee et al., 1977 (Dudley et al., 1972; Eddleston and Williams, 1974) . Such a reaction may be itself cytotoxic or induce a B-cell response to liver specific membrane antigens, responsible for an antibody dependent cell-mediated cytotoxicity. Our results support both these possibilities, showing for the first time that in acute hepatitis B sensitised T cells are produced which are able to destroy HBsAgcoated target cells.
However, direct evidence of a pathogenetic role of these reactions in causing liver cell damage should be obtained by testing with this cytotoxicity technique patients in the prodromic or very early phase of the disease, as only at that time is HBsAg detected in the liver on the hepatocyte membrane (Alberti etal., 1976 could be postulated that, in these cases, as in acute hepatitis B, the reaction is T-cell mediated, though being impaired as a consequence of T-cell defect or hindered by block.ng factors; on the other hand, we cannot exclude the possibility that other cells, mainly K cells, may be involved in the cytotoxic reaction in these patients. This possibility must be considered, as in HBsAg-positive chronic active hepatitis IgG bound to the hepatocyte membrane have been detected and their presence correlates tightly with the activity of the disease (Hopf et al., 1975; ; there is evidence supporting the assumption that these cytophilic antibodies are directed against antigens that are different from normal liver specific membrane proteins (Alberti et al., 1977) . These immunoglobulins may interfere with the T-cell mediated clearance of infected liver cells but may also induce an antibody-dependent cellular (K-cells) cytotoxicity. Further studies are necessary to better characterise the HBsAg-sensitised cytotoxic cell population in patients with antigenpositive chronic active hepatitis and its role in the pathogenesis of the disease.
